Competitive Technologies, Inc. (NYSE Amex: CTT) maximizes the value of intellectual assets for the benefit of its customers, clients and shareholders. Working across a broad spectrum of disciplines and industries, CTT provides distribution, patent and technology transfer, sales and licensing services to intellectual property owners seeking to commercialize their innovative products and technologies.
CTT has a world-class team of professionals with diverse technical, legal, intellectual property, marketing and business experience enabling it to offer a complete spectrum of solutions for the commercial optimization of technology. CTT works with universities, large and small corporations, and federal and private research centers in the U.S. and internationally.
CTT has paid over $100 million to universities in shared technology revenues.
CTT is a vital part of the technology-commercialization community.
CTT hosted the Calmare Pain Therapy Conference May 17th in Boston, MA.
Information
presented during the conference has been made available
for download on the CalmareTT
web site.
What's New
- CTT Announces that NYSE AMEX has Postponed Delisting Hearing
- CTT to Complete Fund Raise to Support Increased Sales of its Calmare® Pain Therapy Treatment
- CTT Expands Calmare® Pain Therapy Sales Force
Media Coverage
Crystal Research - Executive Overview on CTT
Calmare Pain Therapy Device Trials in
India
CTT presents at Taglich Brothers' 7th Annual Small Cap Equity Conference. Interested individuals may watch in real time on May 4th 2010 at 11:45 AM (EST). See the link at www.taglich.com
